UNIVERSITE DE MONTPELLIER 1
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 14, 2017 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 101 Total Citation Count
- Mar 28, 2003 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2011/0038,844 COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITIONApr 08, 09Feb 17, 11[A61K, C12N, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9783541 5′-nucleotidase inhibitors and therapeutic uses thereofSep 29, 14Oct 10, 17[A61K, A01N, C07F, C07D]
9687552 Association of poly(N-acryloylglycinamide) with at least one active principleFeb 26, 13Jun 27, 17[A61J, A61K]
9481863 Methods for determining developmental stage of human cumulus cellsJun 29, 12Nov 01, 16[C12Q, C12N]
9453259 Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulationOct 22, 12Sep 27, 16[C12Q]
9358324 Hydrophobic polymer for producing medical devices visible in MRIJul 07, 10Jun 07, 16[A61K, C08G, C08F, A61L]
9260748 Methods for assessing endometrium receptivity of a patientMay 27, 11Feb 16, 16[C12Q, A61B, C40B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0201,128 METHODS FOR SELECTING COMPETENT OOCYTES AND COMPETENT EMBRYOS WITH HIGH POTENTIAL FOR PREGNANCY OUTCOMEAbandonedJul 24, 15Jul 14, 16[C12Q]
2013/0231,263 METHODS FOR SELECTING COMPETENT OOCYTES AND COMPETENT EMBRYOS WITH HIGH POTENTIAL FOR PREGNANCY OUTCOMEAbandonedOct 18, 11Sep 05, 13[C12Q]
2012/0100,117 METHOD FOR CHONDROGENIC DIFFERENTIATION OF PLURIPOTENT OR MULTIPOTENT STEM CELLS USING WNT6AbandonedApr 24, 09Apr 26, 12[A61K, C12N, A61P]
2011/0256,090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications ThereofAbandonedDec 18, 09Oct 20, 11[A61K, C07H, C12Q, C12N, A61P, C40B]
2010/0240,084 USE OF THE PROTIEN MABA (FABG1) OF MYCOBACTERIUM TUBERCULOSIS FOR DESIGNING AND SCREENING ANTIBIOTICSAbandonedApr 14, 09Sep 23, 10[C07H, C12Q, C12N]
2010/0209,426 INHIBITORS OF PROGASTRIN-INDUCED REPRESSION OF ICAT FOR TREATING AND/OR PREVENTING COLORECTAL CANCER, ADENOMATOUS POLYPOSIS OR METASTASIS DISPLAYING PROGASTRIN-SECRETING CELLS AND CELLS IN WHICH THE BETA-CATENIN/TCF-MEDIATED TRANSCRIPTIONAL PATHWAY IS CONSTITUTIVELY ACTIVEAbandonedMay 21, 07Aug 19, 10[A61K, C07H, C12Q, A61P, C07K]
2009/0291,116 Biocompatible and Biodegradable Porous Matrix in Particular Useful for Tissue ReconstructionAbandonedOct 10, 06Nov 26, 09[C08J, A61K, C12Q, C12N, A61L]
2006/0035,294 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibioticsAbandonedMar 28, 03Feb 16, 06[C12N, G01N, G06F, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.